11/09/2023 |
N/A |
AAOI |
Applied Optoelectronics Inc |
N/A
|
N/A |
N/A |
464 M |
-1.96 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ABSI |
Absci Corp |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
500 M |
-0.93 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ACB |
Aurora Cannabis Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
332 M |
-4.96 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ACDC |
ProFrac Holding Corp - Ordinary Shares Class A |
Oil and Gas Field Machinery and Equipment Manufacturing
|
N/A |
N/A |
1,097 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ACRV |
Acrivon Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
294 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ADVM |
Adverum Biotechnologies Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
144 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AGIL |
AgileThought Inc - Class A |
Marketing Consulting Services
|
N/A |
N/A |
0 M |
-1.46 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AGRX |
Agile Therapeutics Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ACHV |
Achieve Life Sciences Inc. |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
150 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AIRG |
Airgain Inc |
N/A
|
N/A |
N/A |
87 M |
-1.16 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AKLI |
Akili Inc |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ALDX |
Aldeyra Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
342 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ALRM |
Alarm.com Holdings Inc |
N/A
|
N/A |
N/A |
2,932 M |
1.95 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ALT |
Altimmune Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
476 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AMLX |
Amylyx Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
151 M |
-2.41 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
APTO |
Aptose Biosciences Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
7 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
APYX |
Apyx Medical Corp |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
46 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ARAV |
Aravive Inc |
Pharmaceutical Preparation Manufacturing
|
N/A |
N/A |
0 M |
-0.51 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ARQT |
Arcutis Biotherapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1,272 M |
-2.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ARTNA |
Artesian Resources Corp. - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
340 M |
1.78 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ATAI |
ATAI Life Sciences N.V. |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
218 M |
-0.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ATHA |
Athira Pharma Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
119 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AURA |
Aura Biosciences Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
394 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AVAH |
Aveanna Healthcare Holdings Inc |
N/A
|
N/A |
N/A |
1,092 M |
-0.65 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AVPT |
AvePoint Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
2,157 M |
-0.08 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AXDX |
Accelerate Diagnostics Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
47 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
AYRO |
AYRO Inc |
N/A
|
N/A |
N/A |
6 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BBW |
Build A Bear Workshop Inc |
N/A
|
N/A |
N/A |
461 M |
3.49 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BCEL |
Atreca Inc - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BDX |
Becton Dickinson & Co. |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
70,067 M |
4.84 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BEEM |
Beam Global |
N/A
|
N/A |
N/A |
69 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BFX |
BowFlex Inc |
Sporting and Athletic Goods Manufacturing
|
N/A |
N/A |
7 M |
-2.13 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BLFS |
Biolife Solutions Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
1,194 M |
-1.63 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BLNK |
Blink Charging Co |
N/A
|
N/A |
N/A |
188 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BN |
Brookfield Corporation - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
82,674 M |
0.61 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BOLT |
Bolt Biotherapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
26 M |
-1.74 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BRAG |
Bragg Gaming Group Inc |
N/A
|
N/A |
N/A |
126 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BRLT |
Brilliant Earth Group Inc - Ordinary Shares Class A |
N/A
|
N/A |
N/A |
26 M |
0.01 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BW |
Babcock & Wilcox Enterprises Inc |
N/A
|
N/A |
N/A |
109 M |
-2.07 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
BZFD |
BuzzFeed Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
94 M |
-2.29 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CABA |
Cabaletta Bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
275 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CADL |
Candel Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
217 M |
-1.10 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CAPR |
Capricor Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
149 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CCOI |
Cogent Communications Holdings Inc |
N/A
|
N/A |
N/A |
3,429 M |
0.96 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CCSI |
Consensus Cloud Solutions Inc |
N/A
|
N/A |
N/A |
465 M |
4.71 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CELC |
Celcuity Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
591 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CELU |
Celularity Inc - Ordinary Shares - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
68 M |
-110.20 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CGC |
Canopy Growth Corporation |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
444 M |
-6.81 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CIO |
City Office REIT Inc |
Lessors of Nonresidential Buildings (except Miniwarehouses)
|
N/A |
N/A |
236 M |
-0.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CLDX |
Celldex Therapeutics Inc. |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,740 M |
-2.68 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CLFD |
Clearfield Inc |
N/A
|
N/A |
N/A |
531 M |
-0.60 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CLNE |
Clean Energy Fuels Corp |
N/A
|
N/A |
N/A |
690 M |
-0.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CLPT |
ClearPoint Neuro Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
358 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CMAX |
CareMax Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
9 M |
-13.32 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CMPO |
CompoSecure Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
352 M |
0.52 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CNFR |
Conifer Holdings Inc |
N/A
|
N/A |
N/A |
8 M |
-2.10 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CODX |
Co-Diagnostics Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
44 M |
-1.27 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
COMM |
CommScope Holding Company Inc |
N/A
|
N/A |
N/A |
833 M |
-8.13 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CPTN |
Cepton Inc |
N/A
|
N/A |
N/A |
49 M |
-1.65 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CRDL |
Cardiol Therapeutics Inc - Ordinary Shares - Class A |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
136 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CRNX |
Crinetics Pharmaceuticals Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
4,247 M |
-3.76 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CTLP |
Cantaloupe Inc |
Financial Transactions Processing, Reserve, and Clearinghouse Activities
|
N/A |
N/A |
504 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CTSO |
Cytosorbents Corp |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
57 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CWCO |
Consolidated Water Co. Ltd. |
N/A
|
N/A |
N/A |
440 M |
2.56 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
CXDO |
Crexendo Inc |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
138 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DARE |
Dare Bioscience Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
31 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DBTX |
Decibel Therapeutics Inc |
Pharmaceutical Preparation Manufacturing
|
N/A |
N/A |
69 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DCBO |
Docebo Inc |
N/A
|
N/A |
N/A |
1,304 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DDS |
Dillard`s Inc. - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
4,152 M |
43.95 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DERM |
Journey Medical Corp |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
73 M |
0.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DGII |
Digi International, Inc. |
N/A
|
N/A |
N/A |
1,073 M |
0.46 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DICE |
DICE Therapeutics Inc |
Medicinal and Botanical Manufacturing
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DNA |
Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
11,534 M |
-0.45 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DNUT |
Krispy Kreme Inc |
N/A
|
N/A |
N/A |
1,911 M |
-0.31 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DRCT |
Direct Digital Holdings Inc - Ordinary Shares Class A |
N/A
|
N/A |
N/A |
10 M |
0.31 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DRMA |
Dermata Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DSKE |
Daseke Inc |
General Freight Trucking, Local
|
N/A |
N/A |
274 M |
0.34 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DV |
DoubleVerify Holdings Inc |
N/A
|
N/A |
N/A |
3,350 M |
0.35 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DXPE |
DXP Enterprises, Inc. |
N/A
|
N/A |
N/A |
868 M |
3.53 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DYNT |
Dynatronics Corp. |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
1 M |
-1.16 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
DZSI |
DZS Inc |
N/A
|
N/A |
N/A |
0 M |
-3.93 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EBIX |
Ebix Inc. |
Computer Systems Design Services
|
N/A |
N/A |
0 M |
0.16 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EDBL |
Edible Garden AG Inc |
N/A
|
N/A |
N/A |
4 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EDRY |
EuroDry Ltd |
N/A
|
N/A |
N/A |
57 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EQRX |
EQRx Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ETNB |
89bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
935 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ETON |
Eton Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
119 M |
-0.26 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EVBG |
Everbridge Inc |
N/A
|
N/A |
N/A |
0 M |
-1.20 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EVC |
Entravision Communications Corp. - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
168 M |
-1.08 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EVLV |
Evolv Technologies Holdings Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
621 M |
-0.12 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EVOK |
Evoke Pharma Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
4 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EYE |
National Vision Holdings Inc |
N/A
|
N/A |
N/A |
830 M |
-1.08 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
EYEN |
Eyenovia Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
35 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FA |
First Advantage Corp. |
N/A
|
N/A |
N/A |
2,785 M |
0.17 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FEAM |
5E Advanced Materials Inc |
N/A
|
N/A |
N/A |
46 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FENC |
Fennec Pharmaceuticals Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
152 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FIXX |
Homology Medicines Inc |
Pharmaceutical Preparation Manufacturing
|
N/A |
N/A |
35 M |
-2.28 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FLO |
Flowers Foods, Inc. |
N/A
|
N/A |
N/A |
4,894 M |
0.61 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FLUX |
Flux Power Holdings inc |
N/A
|
N/A |
N/A |
55 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FPAY |
FlexShopper Inc |
N/A
|
N/A |
N/A |
24 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FREE |
Whole Earth Brands Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
0 M |
-0.57 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FRGI |
Fiesta Restaurant Group Inc |
Food Service Contractors
|
N/A |
N/A |
218 M |
-0.60 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FRHC |
Freedom Holding Corp |
N/A
|
N/A |
N/A |
5,282 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
FRTX |
Fresh Tracks Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
5 M |
-1.06 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GANX |
Gain Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
28 M |
-1.71 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GDRX |
GoodRx Holdings Inc - Ordinary Shares - Class A |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
779 M |
-0.15 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GERN |
Geron Corp. |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,863 M |
-0.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GHRS |
GH Research PLC |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
546 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GLUE |
Monte Rosa Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
379 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GOCO |
GoHealth Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
85 M |
-6.23 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GRAB |
Grab Holdings Limited - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
12,632 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GRPH |
Graphite Bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
185 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GRPN |
Groupon Inc |
N/A
|
N/A |
N/A |
551 M |
-1.02 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GRTS |
Gritstone Bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
56 M |
-1.08 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GSL |
Global Ship Lease Inc - Ordinary Shares - Class A |
Deep Sea Freight Transportation
|
N/A |
N/A |
883 M |
9.07 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
GTEC |
Greenland Technologies Holding Corp |
N/A
|
N/A |
N/A |
27 M |
-0.93 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HBI |
Hanesbrands Inc |
N/A
|
N/A |
N/A |
2,233 M |
-0.85 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HE |
Hawaiian Electric Industries, Inc. |
N/A
|
N/A |
N/A |
1,184 M |
-10.55 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HGBL |
Heritage Global Inc |
N/A
|
N/A |
N/A |
64 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HHS |
Harte-Hanks, Inc. |
N/A
|
N/A |
N/A |
55 M |
-4.06 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HLVX |
HilleVax Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
93 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HNRG |
Hallador Energy Co |
N/A
|
N/A |
N/A |
286 M |
-0.17 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HNST |
Honest Company Inc (The ) |
Toilet Preparation Manufacturing
|
N/A |
N/A |
467 M |
-0.13 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HOLX |
Hologic, Inc. |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
18,870 M |
2.91 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HOWL |
Werewolf Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
94 M |
-1.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HSON |
Hudson Global Inc |
N/A
|
N/A |
N/A |
50 M |
-0.67 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HSTO |
Histogen Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1 M |
-2.89 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HUMA |
Humacyte Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
722 M |
-0.86 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HYFM |
Hydrofarm Holdings Group Inc |
N/A
|
N/A |
N/A |
20 M |
-1.55 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
HYPR |
Hyperfine Inc - Ordinary Shares - Class A |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
58 M |
-0.58 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IBEX |
IBEX Ltd |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
297 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IBRX |
ImmunityBio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,751 M |
-0.95 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IHRT |
iHeartMedia Inc - Ordinary Shares - Class A New |
N/A
|
N/A |
N/A |
196 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ILLM |
Illumin Holdings Inc |
N/A
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ILMN |
Illumina Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
20,932 M |
-18.81 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INAB |
IN8bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
25 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INBS |
Intelligent Bio Solutions Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
4 M |
-16.32 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INDI |
Indie Semiconductor Inc - Ordinary Shares - Class A |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
744 M |
-0.51 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INKT |
MiNK Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
32 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INSE |
Inspired Entertainment Inc |
N/A
|
N/A |
N/A |
240 M |
0.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
INVA |
Innoviva Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
1,212 M |
1.71 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IPSC |
Century Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
149 M |
-2.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IRON |
Disc Medicine Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1,511 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
IRWD |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
808 M |
0.06 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ITI |
Iteris Inc. |
N/A
|
N/A |
N/A |
302 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ITOS |
ITeos Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
615 M |
-3.15 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
JANX |
Janux Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,451 M |
-0.90 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
JRSH |
Jerash holdings (US) Inc |
N/A
|
N/A |
N/A |
37 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
JYNT |
Joint Corp |
N/A
|
N/A |
N/A |
170 M |
-0.96 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KDNY |
Chinook Therapeutics Inc |
Pharmaceutical Preparation Manufacturing
|
N/A |
N/A |
2,705 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KELYA |
Kelly Services, Inc. - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
750 M |
1.32 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KINS |
Kingstone Cos. Inc |
N/A
|
N/A |
N/A |
96 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KNTE |
Kinnate Biopharma Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KOPN |
Kopin Corp. |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
117 M |
-0.41 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KPRX |
Kiora Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
11 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KRT |
Karat Packaging Inc |
N/A
|
N/A |
N/A |
507 M |
1.41 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KURA |
Kura Oncology Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1,614 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
KZR |
Kezar Life Sciences Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
44 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LCUT |
Lifetime Brands, Inc. |
N/A
|
N/A |
N/A |
158 M |
-0.82 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LEGH |
Legacy Housing Corp |
N/A
|
N/A |
N/A |
656 M |
2.18 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LFLY |
Leafly Holdings Inc |
N/A
|
N/A |
N/A |
5 M |
-2.93 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LIDR |
AEye Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
11 M |
-10.02 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LIFE |
Atyr Pharma Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
131 M |
-0.90 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LNSR |
LENSAR Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
54 M |
-1.11 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LNW |
Light & Wonder Inc |
N/A
|
N/A |
N/A |
9,744 M |
3.29 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LPCN |
Lipocine Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
20 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LPTH |
Lightpath Technologies, Inc. - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
50 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LRMR |
Larimar Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
505 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LTRX |
Lantronix Inc |
N/A
|
N/A |
N/A |
135 M |
-0.18 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LVO |
LiveOne Inc |
N/A
|
N/A |
N/A |
172 M |
-0.14 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
LXRX |
Lexicon Pharmaceuticals Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
625 M |
-0.77 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MDVL |
MedAvail Holdings Inc |
All Other Miscellaneous Chemical Product and Preparation Manufacturing
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MGNX |
Macrogenics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
220 M |
-2.19 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MGTX |
MeiraGTx Holdings plc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
264 M |
-1.49 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MIST |
Milestone Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
76 M |
-1.39 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MKTW |
Marketwise Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
35 M |
0.09 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MMAT |
Meta Materials Inc |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MNOV |
Medicinova Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
74 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MNTK |
Montauk Renewables Inc |
N/A
|
N/A |
N/A |
674 M |
0.13 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MOGO |
Mogo Inc - Ordinary Shares (Sub Voting) |
Credit Card Issuing
|
N/A |
N/A |
30 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MTD |
Mettler-Toledo International, Inc. |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
30,536 M |
36.34 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MTEM |
Molecular Templates Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
10 M |
0.77 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MTSI |
MACOM Technology Solutions Holdings Inc |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
7,885 M |
0.99 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
MVST |
Microvast Holdings Inc |
N/A
|
N/A |
N/A |
91 M |
-0.49 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NERV |
Minerva Neurosciences Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
19 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NKTX |
Nkarta Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
375 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NMG |
Nouveau Monde Graphite Inc |
N/A
|
N/A |
N/A |
177 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NNOX |
Nano X Imaging Ltd |
N/A
|
N/A |
N/A |
368 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NTLA |
Intellia Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,279 M |
-5.48 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NUVA |
Nuvasive Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
0 M |
0.52 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NVMI |
Nova Ltd |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
6,493 M |
4.77 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NVTS |
Navitas Semiconductor Corp |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
553 M |
-0.29 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
NWSA |
News Corp - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
16,317 M |
0.46 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OABI |
OmniAb Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
495 M |
-0.62 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OBLG |
Oblong Inc |
N/A
|
N/A |
N/A |
100 M |
-0.31 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OCX |
Oncocyte Corporation |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
42 M |
-3.95 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ODV |
Osisko Development Corp |
N/A
|
N/A |
N/A |
174 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OPGN |
Opgen Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
0 M |
-26.56 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OPTN |
OptiNose Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
157 M |
-0.34 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ORGN |
Origin Materials Inc |
N/A
|
N/A |
N/A |
230 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ORGO |
Organogenesis Holdings Inc - Ordinary Shares - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
382 M |
-0.12 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ORGS |
Orgenesis Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
31 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ORMP |
Oramed Pharmaceuticals, Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
97 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
OSS |
One Stop Systems Inc |
N/A
|
N/A |
N/A |
53 M |
-0.36 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PAR |
Par Technology Corp. |
N/A
|
N/A |
N/A |
1,959 M |
0.06 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PASG |
Passage Bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
43 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PBLA |
Panbela Therapeutics Inc. |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PEPG |
PepGen Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
314 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PHUN |
Phunware Inc |
N/A
|
N/A |
N/A |
39 M |
-9.15 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PHVS |
Pharvaris NV |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
941 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PLBY |
PLBY Group Inc |
N/A
|
N/A |
N/A |
40 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
POWW |
AMMO Inc |
N/A
|
N/A |
N/A |
189 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PPTA |
Perpetua Resources Corp. |
N/A
|
N/A |
N/A |
575 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PRAX |
Praxis Precision Medicines Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
944 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PRPH |
ProPhase Labs Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
51 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PRPL |
Purple Innovation Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
129 M |
-1.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PRTA |
Prothena Corporation plc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1,198 M |
-0.94 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PSEC |
Prospect Capital Corp |
N/A
|
N/A |
N/A |
2,244 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PSTX |
Poseida Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
278 M |
-1.18 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
PX |
P10 Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
542 M |
0.02 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
QSI |
Quantum-Si Incorporated - Ordinary Shares - Class A |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
116 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RANI |
Rani Therapeutics Holdings Inc - Ordinary Shares Class A |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
94 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RAPT |
RAPT Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
72 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RBA |
RB Global Inc |
N/A
|
N/A |
N/A |
15,870 M |
1.78 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RBC |
RBC Bearings Inc. |
Ball and Roller Bearing Manufacturing
|
N/A |
N/A |
8,706 M |
6.78 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RCEL |
AVITA Medical Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
243 M |
-1.95 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RCI |
Rogers Communications Inc. - Ordinary Shares - Class B |
N/A
|
N/A |
N/A |
17,165 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RDNT |
Radnet Inc |
N/A
|
N/A |
N/A |
4,903 M |
0.14 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
REAX |
The Real Brokerage Inc. |
N/A
|
N/A |
N/A |
1,144 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
REPL |
Replimune Group Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
695 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RGF |
Real Good Food Company Inc (The) - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
9 M |
-2.07 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RGLS |
Regulus Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
110 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RGTI |
Rigetti Computing Inc |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
175 M |
-0.45 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RIGL |
Rigel Pharmaceuticals |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
236 M |
-0.81 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RKDA |
Arcadia Biosciences Inc |
N/A
|
N/A |
N/A |
4 M |
-4.98 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RMBL |
RumbleON Inc - Ordinary Shares - Class B |
N/A
|
N/A |
N/A |
157 M |
-7.22 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RPAY |
Repay Holdings Corporation - Ordinary Shares - Class A |
Financial Transactions Processing, Reserve, and Clearinghouse Activities
|
N/A |
N/A |
742 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RPTX |
Repare Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
124 M |
-1.61 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RSSS |
Research Solutions Inc |
N/A
|
N/A |
N/A |
90 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RVLP |
RVL Pharmaceuticals plc |
Medicinal and Botanical Manufacturing
|
N/A |
N/A |
0 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
RXST |
RxSight Inc |
N/A
|
N/A |
N/A |
2,098 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SCSC |
Scansource, Inc. |
Computer and Computer Peripheral Equipment and Software Merchant Wholesalers
|
N/A |
N/A |
1,224 M |
3.06 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SCYX |
Scynexis Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
55 M |
-0.73 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SIX |
Six Flags Entertainment Corp |
Amusement and Theme Parks
|
N/A |
N/A |
1,980 M |
1.25 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SKE |
Skeena Resources Ltd |
N/A
|
N/A |
N/A |
815 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SKIN |
Beauty Health Company (The) - Ordinary Shares - Class A |
Toilet Preparation Manufacturing
|
N/A |
N/A |
222 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SLDB |
Solid Biosciences Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
345 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SLGL |
Sol-Gel Technologies Ltd |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
19 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SMLR |
Semler Scientific Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
187 M |
2.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SOUN |
SoundHound AI Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
1,594 M |
-0.41 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SST |
System1 Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
86 M |
-2.46 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
STN |
Stantec Inc |
N/A
|
N/A |
N/A |
9,352 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
STRR |
Star Equity Holdings Inc |
N/A
|
N/A |
N/A |
13 M |
-2.78 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SVRA |
Savara Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
703 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SYBX |
Synlogic Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
17 M |
-5.44 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
SYNA |
Synaptics Inc |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
3,223 M |
3.16 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TACT |
Transact Technologies Inc. |
N/A
|
N/A |
N/A |
42 M |
-0.05 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TARS |
Tarsus Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
1,031 M |
-4.38 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TAST |
Carrols Restaurant Group Inc. |
N/A
|
N/A |
N/A |
0 M |
0.56 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TDG |
Transdigm Group Incorporated |
N/A
|
N/A |
N/A |
77,053 M |
27.04 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TELA |
TELA Bio Inc |
N/A
|
N/A |
N/A |
72 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TGAN |
Transphorm Inc |
Semiconductor and Related Device Manufacturing
|
N/A |
N/A |
171 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TH |
Target Hospitality Corp - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
973 M |
1.18 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
THAR |
Tharimmune Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
3 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
THMO |
ThermoGenesis Holdings Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
0 M |
-4.82 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TKNO |
Alpha Teknova Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
263 M |
-0.90 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TLS |
Telos Corp |
N/A
|
N/A |
N/A |
264 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TMCI |
Treace Medical Concepts Inc |
Surgical and Medical Instrument Manufacturing
|
N/A |
N/A |
384 M |
-1.03 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TNGX |
Tango Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
1,268 M |
-1.11 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TNYA |
Tenaya Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
211 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TPR |
Tapestry Inc |
N/A
|
N/A |
N/A |
9,432 M |
3.50 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TRML |
Tourmaline Bio Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
432 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TRVI |
Trevi Therapeutics Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
229 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TRVN |
Trevena Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
84 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TSP |
TuSimple Holdings Inc - Class A |
General Freight Trucking, Local
|
N/A |
N/A |
0 M |
-1.58 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TSQ |
Townsquare Media Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
154 M |
-5.26 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TTD |
Trade Desk Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
46,794 M |
0.51 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
TWOU |
2U Inc |
N/A
|
N/A |
N/A |
0 M |
-216.24 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
UGRO |
Urban-gro Inc |
N/A
|
N/A |
N/A |
17 M |
-1.35 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
UP |
Wheels Up Experience Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
1,235 M |
-0.90 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
URGN |
UroGen Pharma Ltd |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
586 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
USEG |
U.S. Energy Corp. |
N/A
|
N/A |
N/A |
26 M |
-1.58 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
UTZ |
Utz Brands Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
1,394 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VERA |
Vera Therapeutics Inc - Ordinary Shares - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
2,074 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VERX |
Vertex Inc - Ordinary Shares Class A |
N/A
|
N/A |
N/A |
2,529 M |
0.13 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VIGL |
Vigil Neuroscience Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
138 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VIRX |
Viracta Therapeutics Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
8 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VLCN |
Volcon Inc |
N/A
|
N/A |
N/A |
7 M |
-340.11 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VOR |
Vor Biopharma Inc |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
60 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VRCA |
Verrica Pharmaceuticals Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
100 M |
-1.88 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VTGN |
Vistagen Therapeutics Inc. |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
94 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VTVT |
vTv Therapeutics Inc - Ordinary Shares - Class A |
Research and Development in Biotechnology (except Nanobiotechnology)
|
N/A |
N/A |
38 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VUZI |
Vuzix Corporation |
N/A
|
N/A |
N/A |
57 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VVV |
Valvoline Inc |
N/A
|
N/A |
N/A |
5,438 M |
1.26 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
VWE |
Vintage Wine Estates Inc |
N/A
|
N/A |
N/A |
0 M |
-2.32 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WBX |
Wallbox N.V - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
235 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WD |
Walker & Dunlop Inc |
Mortgage and Nonmortgage Loan Brokers
|
N/A |
N/A |
3,613 M |
2.59 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WEST |
Westrock Coffee Company |
N/A
|
N/A |
N/A |
706 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WHF |
WhiteHorse Finance Inc |
N/A
|
N/A |
N/A |
276 M |
0.00 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WIX |
Wix.com Ltd |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
9,134 M |
1.26 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WPM |
Wheaton Precious Metals Corp |
N/A
|
N/A |
N/A |
28,039 M |
1.26 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WRAP |
Wrap Technologies Inc |
N/A
|
N/A |
N/A |
78 M |
-0.71 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WRK |
WestRock Co |
Corrugated and Solid Fiber Box Manufacturing
|
N/A |
N/A |
8,821 M |
-5.52 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WVE |
Wave Life Sciences Ltd. |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
716 M |
-0.62 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
WWW |
Wolverine World Wide, Inc. |
Footwear Manufacturing
|
N/A |
N/A |
1,097 M |
-1.22 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
XELA |
Exela Technologies Inc |
Data Processing, Hosting, and Related Services
|
N/A |
N/A |
134 M |
-17.02 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
XERS |
Xeris Biopharma Holdings Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
419 M |
-0.42 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
XMTR |
Xometry Inc - Ordinary Shares - Class A |
N/A
|
N/A |
N/A |
916 M |
-1.09 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
XOS |
Xos Inc |
N/A
|
N/A |
N/A |
40 M |
-7.54 |
N/A
|
N/A |
N/A |
N/A |
11/09/2023 |
N/A |
ZVRA |
Zevra Therapeutics Inc |
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
|
N/A |
N/A |
403 M |
-1.67 |
N/A
|
N/A |
N/A |
N/A |